• 1
    Ziello C, Sparks TH, Estrella N, et al. Changes to airborne pollen counts across Europe. PLoS ONE. 2012;7: e34076.
  • 2
    Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl. 86): 8160.
  • 3
    Burney P, Chinn S, Jarvis D, Luczynska C, Lai E, on behalf of the European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1996;9: 687695.
  • 4
    Weinmayr G, Forastiere F, Weiland SK, et al. International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur Respir J. 2008;32: 12501261.
  • 5
    Yorgancioglu A, Ozdemir C, Kalayci O, et al. ARIA (Allergic Rhinitis and Its Impact on Asthma) achievements in 10 years and future needs. Tuberk Toraks. 2012;60: 9297.
  • 6
    Feng CH, Miller MD, Simon RA. The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy. 2012;26: 187190.
  • 7
    Pawankar R. Allergic rhinitis and asthma: are they manifestations of one syndrome? Clin Exp Allergy. 2006;36: 14.
  • 8
    Mosges R, El Hassan E. Emerging areas of interest in the management and treatment of allergic rhinitis. Eur Respir Dis. 2011;7: 6166.
  • 9
    Pullerits T, Praks L, Ristioja V, Lotvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109: 949955.
  • 10
    Emberlin JC, Lewis RA. A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin. 2007;23: 24232431.
  • 11
    Emberlin JC, Lewis RA. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin. 2006;22: 275285.
  • 12
    Schwetz S, Olze H, Melchisedech S, Grigorov A, Latza R. Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2004;130: 979984.
  • 13
    Klimek L, Gene-Schneider S, Mösges R, Hörmann K. Die Pollenschutzcreme SIMAROline ist wirkungslos bei saisonaler allergischer Rhinitis. Allergologie. 2000;23: 455460.
  • 14
    Lee CH, Moturi V, Lee Y. Thixotropic property in pharmaceutical formulations. J Control Release. 2009;136: 8898.
  • 15
    Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter W, Tasman AJ, Wagenmann M. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J. 2002;11: 2936.
  • 16
    Luond-Valeskeviciute I, Haenggi B, Gruenwald J. Efficacy of three thixotropic nasal spray preparations on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. WebmedCentral ALLERGY. 2010;1(10): WMC00993.
  • 17
    Therapieerfolge mit Meerwasser. Naturheilpraxis 1999, 3: Available at: (accessed 9 December 2013).
  • 18
    Cordray S, Harjo JB, Miner L. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear Nose Throat J. 2005;84: 426430.
  • 19
    Wabnitz DA, Wormald PJ. A blinded, randomized, controlled study on the effect of buffered 0.9% and 3% sodium chloride intranasal sprays on ciliary beat frequency. Laryngoscope. 2005;115: 803805.